Presence of a general irritation and inhibition of a local inflammation.
D000085:Acetates / Q000627:therapeutic use*; D000818:Animals; D001241:Aspirin / Q000627:therapeutic use*; D001769:Blood; D002351:Carrageenan / Q000494:pharmacology; D004396:Coloring Agents / Q000032:analysis* / Q000378:metabolism*; D004487:Edema / Q000139:chemically induced* / Q000188:drug therapy*; D005260:Female; D005557:Formaldehyde / Q000627:therapeutic use*; D006982:Hypertonic Solutions / Q000627:therapeutic use*; D007082:Ileum / Q000032:analysis; D007213:Indomethacin / Q000627:therapeutic use*; D007249:Inflammation / Q000139:chemically induced* / Q000188:drug therapy*; D010653:Phenylbutazone / Q000627:therapeutic use*; D051381:Rats; D012965:Sodium Chloride / Q000627:therapeutic use; D013270:Stomach / Q000032:analysis; D015003:Yeasts
D000085:Acetates; D004396:Coloring Agents; D006982:Hypertonic Solutions; D005557:Formaldehyde; D012965:Sodium Chloride; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin